FDA Inspection 787010 — L & M Pharmaceuticals, Inc.

L & M Pharmaceuticals, Inc. — FEI 1626923

The FDA completed an inspection of L & M Pharmaceuticals, Inc. on June 19, 2012 in Redfield, AR. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 10 citations were issued during this inspection. Product area: Veterinary.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
June 19, 2012
Fiscal Year
2012
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Redfield, AR (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
113321 CFR 211.25(a)GMP Training Frequency
116921 CFR 211.42(a)Buildings of Suitable Size, Construction, Location
136121 CFR 211.100(a)Absence of Written Procedures
188321 CFR 211.165(a)Testing and release for distribution
191421 CFR 211.166(a)Lack of written stability program
194321 CFR 211.180(e)(1)Review of representative number of batches
241921 CFR 211.198(a)Complaint Handling Procedure
355921 CFR 211.56(a)Sanitation--buildings not clean, free of infestation
431421 CFR 211.84(d)(2)Reports of Analysis (Components)